Lv11
58 积分 2025-10-09 加入
[177Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial
2小时前
待确认
PET in myeloma redefined: a comparative imaging study with FDG and fluorocholine PET/CT
1个月前
已完结
Chemokine receptor-4 targeted PET/CT with 68Ga-Pentixafor in assessment of newly diagnosed multiple myeloma: comparison to 18F-FDG PET/CT
3个月前
已完结
Imaging and bone marrow assessments improve minimal residual disease prediction in multiple myeloma
3个月前
已完结
Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group
3个月前
已完结
Molecular imaging of renal cell carcinomas: ready for prime time
3个月前
已完结
Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network
3个月前
已完结
Dermatological toxicities of talquetamab, a new bispecific antibody: case series and literature review
3个月前
已完结
Anti-GPRC5D CAR T-cell therapy as a salvage treatment in patients with progressive multiple myeloma after anti-BCMA CAR T-cell therapy: a single-centre, single-arm, phase 2 trial
3个月前
已完结
Genetic and epigenetic mechanisms of GPRC5D loss after anti-GPRC5D CAR T-cell therapy in multiple myeloma
3个月前
已完结
皖公网安备34019202002308
